Sixth Annual New York Lung Cancer Symposium

Last Modified: September 15, 2010

Share article


Conference Dates: November 9, 2010
Conference Location: The Westin New York at Times Square

Sponsoring Group: Physicians' Education Resource

Conference Web Page URL: http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/565
Topics Covered: Assess molecular profiling of lung cancer based on tumor characteristics Summarize the optimal approach to adjuvant chemotherapy for patients with early-stage NSCLC Discuss the efficacy and toxicity of combined modality regimens in locally advanced NSCLC Analyze approaches to optimize the use of EGFR inhibitors in patients with EGFR mutations Evaluate clinical data on maintenance therapy with cytotoxic/targeted agents in advanced NSCLC Assess clinical data on novel agents in development for lung cancer Assess potential benefits of clinical trials for individual patients with lung cancer

Who Should Attend: Medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals

Registration Information: http://www.cancerlearning.com/index.cfm/fuseaction/conference.showRegistration/id/5/conference_id/565

Conference Fees: $195

Continuing Education: Yes

Miscellany: Maximum of 7.5 AMA PRA Category 1 Credits